Tag:
Vicept
Latest Headlines
Latest Headlines
NJ wins heated competition for Allergan's new R&D facility
New Jersey officials are celebrating Allergan's ( $AGN ) decision to build a new 100,000-square-foot, $12 million R&D facility in the state, adding up to 400 research jobs over the next five years.
Allergan scoops up fledgling Vicept in $275M buyout pact
Flush with Botox bucks, Allergan has struck a deal to buy Vicept Therapeutics for $75 million upfront and up to $200 million in milestones, snaring an mid-stage topical treatment for rosacea. Adding
Vicept wraps $16M venture round
Malvern, PA-based Vicept Therapeutics has nailed down a $10 million investment, wrapping a $16 million Series A to back its development of a topical therapy for rosacea. The developer says that it
